Inventor
TORTOLANI DAVID R
US18 patents
⚠️ This page may combine multiple inventors who share the name “TORTOLANI DAVID R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS5559248ASep 24, 1996
Retinoid-like heterocycles
BRISTOL MYERS SQUIBB CO93 citations96
US5523457AJun 4, 1996
Retinoid-like compounds
BRISTOL MYERS SQUIBB CO61 citations96
US7723336B2May 25, 2010
Fused heterocyclic compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO50 citations94
US5648385AJul 15, 1997
Retinoid-like compounds
BRISTOL MYERS SQUIBB CO36 citations92
US5618839AApr 8, 1997
Retinoid-like compounds
BRISTOL MYERS SQUIBB CO37 citations92
US6995181B2Feb 7, 2006
Modulators of the glucocorticoid receptor and method
BRISTOL MYERS SQUIBB CO23 citations90
US6225324B1May 1, 2001
Antidepressant heterocyclic compounds
BRISTOL MYERS SQUIBB CO11 citations74
US11306092B2Apr 19, 2022
Amino indole compounds useful as TLR inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US9492460B2Nov 15, 2016
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US10660877B2May 26, 2020
Pyridyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations72
US10053454B2Aug 21, 2018
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US5849923ADec 15, 1998
Heterocyclic-substituted naphthalenyl retinobenzoic acid derivatives
BRISTOL MYERS SQUIBB CO3 citations63
US12473290B2Nov 18, 2025
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO0 citations51
US11739098B2Aug 29, 2023
Substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations51
US10196387B2Feb 5, 2019
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7968577B2Jun 28, 2011
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations40